Tuesday, August 31, 2021 12:23:28 AM
Zoetis creator of Covid-19 Vaccine for animals.
The Detroit Zoo in Michigan has launched a drive to vaccinate its animals against Covid-19, using a specially designed shot to immunize gorillas, lions, chimpanzees and other critters thought to be most susceptible to the virus.
Joining more than 5 million fully vaccinated Michiganders – humans, that is – some animals at the Detroit Zoo are now being inoculated with a special vaccine created for veterinary use, the Detroit Zoological Society (DZS) announced in a statement on Monday.
“Much like we vaccinate dogs for things like parvovirus, distemper or rabies, this is needed to protect animals at the Zoo,” said Dr. Ann Duncan, director of animal health for the DZS.
Detroit Zoo's most susceptible animals are getting COVID-19 vaccinations
Detroit Zoo's most susceptible animals are getting COVID-19 vaccinations
freep.com
Developed by Zoetis – a pharma firm whose research team is based in Kalamazoo, Michigan – the animal-specific vaccine was first administered to gorillas, chimpanzees, tigers and lions at the Detroit facility. While the zoo said none of its animals have yet contracted the illness, it noted that cases have been detected at other American zoos, and that a tiger and a lion had died from the virus at facilities in India and Europe, suggesting risk of infection does exist for many animals.
“We’re both thankful and relieved a special vaccine is now available to protect against Covid-19,” Scott Carter, chief life sciences officer for the zoological society, added.
Many of the mammals are trained to present themselves to our animal care staff for minor medical procedures, including vaccinations.
Eight lions contract Covid-19 at Hyderabad zoo amid coronavirus surge in India
The Zoetis jab was first unveiled earlier this year at a zoo in San Diego, California, where four orangutans and five bonobos became the first non-human primates to be vaccinated against the virus. Eight gorillas at the same zoo had previously tested positive for the virus – reportedly the first of their species to do so – but were not vaccinated as they were thought to have developed natural immunity.
Though the company originally developed the formulation for dogs and cats, it appears to have worked as intended in other animals and has triggered no adverse reactions.
Zoetis is not the only pharma firm looking to produce jabs for other creatures, however, with the Russian-developed Carnivac-Cov vaccine officially registered by the country’s regulators last March. Touted by its creators as “the first, and to date, the only Covid-19 product in the world for animals,” the vaccine was proven effective for dogs, cats, arctic foxes and minks, among others.
Recent ZTS News
- Zoetis Announces First Quarter 2024 Results • Business Wire • 05/02/2024 11:00:00 AM
- Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health • Business Wire • 04/28/2024 10:30:00 PM
- Zoetis Foundation Champions Global Veterinarian Education, Well-being, and Livelihoods on World Veterinary Day and Beyond • Business Wire • 04/25/2024 11:00:00 AM
- Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors • Business Wire • 04/01/2024 08:30:00 PM
- Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results • Business Wire • 03/28/2024 12:30:00 PM
- GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News • IH Market News • 03/27/2024 10:54:47 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 08:23:45 PM
- Zoetis to Participate in the Barclays Global Healthcare Conference • Business Wire • 03/05/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:38:47 PM
- Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit • Business Wire • 02/21/2024 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 10:23:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:04:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:14:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:13:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:12:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:11:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:09:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:07:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:07:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/13/2024 10:06:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/13/2024 07:33:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 12:06:12 PM
- Zoetis Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/13/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:57:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:55:49 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM